Search

everythinglearnresearchcommunity

for

Search:↓

Ixekizumab is effective and safe for patients who did not improve with etanercept treatment for psoriasis.

Ixekizumab helps improve life quality, physical ability, and work performance in patients with psoriatic arthritis who haven't used biologic drugs before.

The document concludes that proper treatment and management of plaque psoriasis in adolescents can improve their quality of life.

New cytokine-targeted therapies show promise for treating alopecia areata.

Ixekizumab may be an effective first treatment for a rare skin condition causing hair loss.

Two patients with psoriasis grew extra hair after using certain psoriasis medications.

Ixekizumab successfully treated a rare hair loss condition, leading to complete hair regrowth.

Switching from adalimumab to ixekizumab improved a patient's psoriasis and reversed hair whitening.

New treatments for ichthyosis, like protein replacement and gene therapy, show promise and may become standard care.

Upadacitinib effectively treated a patient with multiple inflammatory conditions.

In 2019, dermatology and venereology improved skin cancer imaging, advanced in treating skin conditions like psoriasis, and explored the skin microbiome's role in diseases.

Lichen planus may be associated with a higher risk of metabolic syndrome.

A woman has a permanent hair loss condition treated with steroids and new medicines, but hair might not regrow.

People on immune-modifying skin disease treatments may have a weaker antibody response to COVID-19 vaccines but often improve after the second dose.

CGF therapy may effectively treat psoriasis by reducing inflammation.

Demodicosis is common and often missed, needing more recognition and treatment in skin care.

Blocking IL-17 can reduce skin inflammation in a mouse model of pityriasis rubra pilaris.

Applying an extract from Perilla frutescens helps hair grow and fights the effects of hair loss hormones.

Follicular mucinosis can be an early sign of aggressive mycosis fungoides.

Up to half of people experience itchy scalp, often due to skin conditions like seborrheic dermatitis or psoriasis, and treatments vary based on the specific cause.

Personalized medicine in dermatology uses molecular biomarkers to improve diagnosis and treatment but needs further advancements for practical use.

There are still challenges in diagnosing and treating chronic skin diseases, but there is hope for future improvements.

Biologics show promise in treating various stubborn skin diseases, but more research and better reimbursement criteria are needed.

The model and estimator can predict drug exposure in kidney transplant patients well.

The conclusion is that skin and hair patterns are formed by a mix of cell activities, molecular signals, and environmental factors.

Extracellular vesicles show promise for treating psoriasis by reducing inflammation and skin lesions.

Drug repositioning offers hope for new, affordable treatments for a genetic skin disorder called ARCI.

Colchicine might help treat different skin diseases, but more research is needed to confirm its effectiveness and safe dosage.

Psoriasis is linked to other autoimmune diseases and involves a specific inflammatory process.

Recognizing scalp symptoms in PRP is crucial for proper diagnosis and treatment.